# Italy Extracorporeal Membrane Oxygenation Machine Market > Italy Extracorporeal Membrane Oxygenation Machine Market Research Report: Size, Share, Trend Analysis By Applications (Cardiac Support, Respiratory Support, Cardiopulmonary Bypass), By End Users (Hospitals, Ambulatory Surgical Centers, Home Care Settings), By Product Type (Venoarterial ECMO, Venovenous ECMO, Arteriovenous ECMO) and By Component (Membrane Oxygenator, Blood Pumps, Heat Exchangers) - Growth Outlook & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 5.9% - **2024:** $ 55.91 Million - **2025:** $ 59.21 Million - **2035:** $ 105 Million - **Key Players:** Medtronic (US), Getinge (SE), LivaNova (GB), Fresenius SE (DE), Terumo Corporation (JP), Maquet (DE), Nipro Corporation (JP), Cleveland Medical Devices (US) **Report ID:** MRFR/MED/49075-HCR · **Pages:** 200 · **Author:** Rahul Gotadki & Garvit Vyas · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/italy-extracorporeal-membrane-oxygenation-machine-market-50832 --- ## Market Summary ## **Italy Extracorporeal Membrane Oxygenation Machine Market Overview** As per MRFR analysis, the Italy Extracorporeal Membrane Oxygenation Machine Market Size was estimated at 44 (USD Million) in 2023. The Italy Extracorporeal Membrane Oxygenation Machine Market Industry is expected to grow from 46.5 (USD Million) in 2024 to 73.3 (USD Million) by 2035. The Italy Extracorporeal Membrane Oxygenation Machine Market CAGR (growth rate) is expected to be around 4.224% during the forecast period (2025 - 2035). ### **Key Italy Extracorporeal Membrane Oxygenation Machine Market Trends Highlighted** The Italy Extracorporeal Membrane Oxygenation (ECMO) machine market is currently experiencing several significant trends shaped by a combination of evolving healthcare needs and advancements in medical technology. One of the key market drivers is the increasing prevalence of respiratory and cardiac diseases, which has led to a growing demand for ECMO services within hospitals. The Italian healthcare system has recognized the necessity for advanced life support systems, driving investments in ECMO machines to improve patient outcomes in critical care settings. Additionally, the rise in awareness about ECMO's benefits among healthcare professionals and patients has spurred implementation across various medical facilities, encouraging faster adoption rates. Further research into the implementation of ECMO in a variety of clinical scenarios, particularly during emergencies such as pandemics or natural disasters, is an opportunity that should be investigated. Italy has made substantial progress in the integration of ECMO technology into acute care procedures, thereby increasing the overall efficiency of health services, thereby advancing emergency response protocols. The emphasis on training and education for medical personnel regarding ECMO procedures is also essential, as the effective use of this technology is contingent upon the presence of skilled personnel. In recent years, there has been a significant increase in the number of collaborative initiatives between hospitals and research institutions that are designed to enhance ECMO systems. This collaboration has encouraged innovation in design and functionality in response to the challenges posed by extant machines. Additionally, the integration of ECMO machines with telemedicine platforms is being driven by the ongoing digital transformation in healthcare, which enables the more effective monitoring and management of patients' conditions remotely. Italy's dedication to the advancement of its healthcare infrastructure, in conjunction with its emphasis on innovative medical technologies, anticipates substantial evolution in the ECMO market in the years ahead. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **Italy Extracorporeal Membrane Oxygenation Machine Market Drivers** ### **Increasing Incidence of Cardiac and Respiratory Disorders** Italy has seen a significant rise in the prevalence of cardiac and respiratory disorders, which are pivotal indications for the use of Extracorporeal Membrane Oxygenation Machines. According to the Italian Ministry of Health, cardiovascular diseases accounted for approximately 35% of all deaths in Italy in 2021. This alarming statistic has driven the healthcare system to invest more in therapies and technologies such as Extracorporeal Membrane Oxygenation, fostering a growing market in the Italy Extracorporeal Membrane Oxygenation Machine Market Industry. Major healthcare institutions, like the National Institute of Health in Italy, are recognizing the importance of early intervention in cardiac conditions, thus advocating for technological advancements that include ECMO systems to mitigate mortality rates. Additionally, in light of the COVID-19 pandemic, respiratory issues have surged, with the Italian Institute of Statistics reporting that lung diseases have increased by 15% over the last three years, necessitating the expanded use of Extracorporeal Membrane Oxygenation Machines to support patients. ### **Technological Advancements in ECMO Systems** Technological innovation is a key driver for the Italy Extracorporeal Membrane Oxygenation Machine Market. Recent developments in ECMO systems have enhanced their efficiency, reliability, and usability. Italian universities and research institutions, such as the University of Bologna, have been active in conducting Research and Development to improve ECMO methodologies, resulting in new features such as portable ECMO machines and simplified cannulation techniques. These advancements not only expand the applicability of ECMO in non-hospital settings but also align with the healthcare sector's shift towards personalized medicine. The investment in technological advancements, supported by collaboration from leading companies like Sorin Group, has led to significant improvements in patient outcomes, further catalyzing the adoption of ECMO machines across Italy. ### **Growth of Healthcare Infrastructure and Funding** The Italian government has committed to improving healthcare infrastructure, which is beneficial for market growth in Extracorporeal Membrane Oxygenation Machines. In recent years, Italy has seen an increase in healthcare expenditures, estimated at around 9% of its GDP, according to the Italian Health Ministry. This increased funding is being directed toward acquiring advanced medical technologies, including ECMO systems, to enhance critical care facilities. Additionally, various regional healthcare initiatives aiming to streamline critical care have played a role in advancing the adoption of ECMO technology, leading to favorable conditions for the Italy Extracorporeal Membrane Oxygenation Machine Market Industry. As major hospitals like Policlinico Gemelli in Rome expand their capabilities, the demand for ECMO equipment is expected to rise significantly to meet the needs of a growing patient population. ### **Increase in Emergency and Critical Care Procedures** The rise in emergency and critical care procedures within Italy is becoming a significant driver for the adoption of Extracorporeal Membrane Oxygenation Machines. Data from the Italian Association of Hospital Emergency Departments indicates that emergency room visits have increased by approximately 20% over the last five years, partly due to an aging population and the surge in chronic diseases. Hospitals face the challenge of managing life-threatening conditions quickly, necessitating advanced treatment options like ECMO. Institutions such as the National Health Service in Italy are now emphasizing the need for immediate access to life-support technologies, thereby boosting the relevance of ECMO systems in critical care settings. This upward trend underscores the potential for growth in the Italy Extracorporeal Membrane Oxygenation Machine Market Industry as healthcare systems adapt to higher emergency care demand. ## **Italy Extracorporeal Membrane Oxygenation Machine Market Segment Insights** ### **Extracorporeal Membrane Oxygenation Machine Market Application Insights** The Italy Extracorporeal Membrane Oxygenation Machine Market, specifically within the Application segment, demonstrates significant relevance to healthcare providers and professionals due to its pivotal role in critical care settings. Various applications such as Cardiac Support, Respiratory Support, and Cardiopulmonary Bypass underline the market's broad utility in managing life-threatening conditions. In the domain of Cardiac Support, the utilization of extracorporeal membrane oxygenation (ECMO) machines facilitates the management of severe cardiac failure, providing crucial time for recovery or surgical intervention and is particularly essential in cases of cardiac arrest or severe heart failure. Respiratory Support caters to an equally important aspect, especially in the treatment of acute respiratory distress syndrome (ARDS) and other severe respiratory conditions, where traditional respiratory support methods may fall short, greatly enhancing patient outcomes through advanced oxygen delivery. Cardiopulmonary Bypass serves as a critical technique during surgical procedures, particularly cardiac surgeries, by temporarily taking over the function of the heart and lungs, allowing surgeons to perform operations with reduced complications, emphasizing its vital importance in the operating room. The dominant presence of these applications within the Italy Extracorporeal Membrane Oxygenation Machine Market reflects a growing need for advanced medical devices that meet rising clinical demand amidst challenges such as chronic diseases and aging populations. As hospitals increasingly adopt cutting-edge technologies, the focus on these applications is likely to deepen, driven by the necessity for better patient care and improved health outcomes. Moreover, innovations in ECMO technology alongside supportive government health initiatives position the Italy Extracorporeal Membrane Oxygenation Machine Market for robust expansion, making it a significant component in the broader healthcare landscape. The combination of technological advancements and the increasing prevalence of conditions necessitating these critical applications underscores the vital role of ECMO systems in modern medicine, showcasing their importance in sustaining life during medical emergencies. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **Extracorporeal Membrane Oxygenation Machine Market End User Insights** The Italy Extracorporeal Membrane Oxygenation Machine Market is significantly influenced by its End User segment, which comprises Hospitals, Ambulatory Surgical Centers, and Home Care Settings. Hospitals are crucial for the deployment of extracorporeal membrane oxygenation machines due to their advanced infrastructure and comprehensive critical care services, positioning them as the primary users of this technology. Ambulatory Surgical Centers are also important, as they provide convenient and timely access to less complex procedures, thereby facilitating rapid patient recovery with ECMO support when needed. Home Care Settings are gaining traction as they offer a more personalized care approach for patients requiring long-term support, reflecting a growing trend towards at-home medical management, especially in chronic conditions. The demand for these machines in these End User categories continues to rise due to increasing prevalence of respiratory and cardiac diseases, along with advancements in technology and treatment protocols. With a focus on improving patient outcomes and experiences, the market dynamics suggest a balancing act between efficiency and innovative care solutions across these diverse settings in Italy's healthcare landscape. ### **Extracorporeal Membrane Oxygenation Machine Market Product Type Insights** The Italy Extracorporeal Membrane Oxygenation Machine Market is witnessing a notable segmentation in the Product Type category, which is critical for addressing diverse patient needs and clinical applications. The Venoarterial ECMO system is particularly significant as it provides circulatory support for patients experiencing severe cardiac failure, allowing for temporary stabilization in critical situations. This product type plays a dominant role in emergency and surgical settings, especially in regions where advanced cardiac care is available. Venovenous ECMO focuses on providing respiratory support, primarily utilized for patients with severe respiratory failure or acute respiratory distress syndrome, thus catering to a specific demographic in need of effective oxygenation while preserving the heart's function. Lastly, Arteriovenous ECMO combines both venous and arterial blood flows and is less common but essential in unique clinical scenarios, demonstrating the versatility needed in advanced life support systems. The unique attributes of each ECMO type contribute to the overall growth and demand within the Italy Extracorporeal Membrane Oxygenation Machine Market, as healthcare providers increasingly rely on these technologies to manage critical situations. ### **Extracorporeal Membrane Oxygenation Machine Market Component Insights** The Component segment of the Italy Extracorporeal Membrane Oxygenation Machine Market plays a crucial role in the overall functionality and efficiency of these life-support systems. Key components such as Membrane Oxygenators are essential for oxygenating blood, thereby significantly improving patient outcomes during critical care situations. Blood Pumps ensure optimal blood circulation and are vital for maintaining stable hemodynamic conditions, contributing to the effectiveness of the extracorporeal membrane oxygenation process. Heat Exchangers are significant in regulating the temperature of blood, preventing complications that may arise due to temperature fluctuations. As Italy faces increasing incidences of respiratory and cardiac conditions, the demand for advanced oxygenation technologies is expected to rise, driving the growth of this segment. The emphasis on quality and technological innovation within these components aligns with the country's commitment to enhancing healthcare delivery. The Component segment shows strong market potential due to continuous improvements in design and functionality, driven by advancements in medical technology and increased investments in healthcare infrastructure. Overall, this segment is poised to make a significant impact on the Italy Extracorporeal Membrane Oxygenation Machine Market as healthcare providers seek more efficient and reliable systems to support critically ill patients. ## **Italy Extracorporeal Membrane Oxygenation Machine Market Key Players and Competitive Insights** The competitive landscape of the Italy Extracorporeal Membrane Oxygenation Machine Market is characterized by a dynamic interplay of various factors including technological advancements, regulatory policies, and evolving healthcare needs. This market has witnessed significant growth driven by rising incidences of respiratory and cardiac conditions, alongside an increasing awareness of ECMO's role in critical care settings. As the demand for effective life support solutions escalates, companies within this sector are investing in innovation, product development, and strategic partnerships to enhance their market penetration and sustain competitive advantage. The ongoing evolution of ECMO technology, alongside demographic shifts towards aging populations, ensures that competition remains intense, prompting firms to continually reassess their strategies in light of emerging trends. LivaNova stands out in the Italy Extracorporeal Membrane Oxygenation Machine Market due to its established reputation and commitment to innovation. With a strong emphasis on research and development, LivaNova has succeeded in launching advanced ECMO systems tailored to meet the specific needs of Italian healthcare providers. This company has effectively leveraged its expertise in medical technology to drive product enhancements that focus on safety, performance, and ease of integration into existing hospital infrastructures. The strength of LivaNova lies not only in its product portfolio, which includes state-of-the-art ECMO machines, but also in its robust customer service and support systems that ensure seamless operation and patient care. Established relationships with key hospitals and healthcare institutions in Italy further solidify LivaNova's market presence, positioning it as a reliable partner in critical care. Asahi Kasei Medical has made significant inroads into the Italy Extracorporeal Membrane Oxygenation Machine Market, emphasizing the development of cutting-edge products and solutions tailored for high-demand clinical environments. With a diverse range of ECMO devices and a well-rounded suite of services, Asahi Kasei Medical focuses on delivering high-quality patient care while addressing the specific needs of healthcare professionals. The company's strengths lie in its innovation-driven approach, with key products including advanced membrane oxygenators and integrated ECMO systems that ensure optimal functionality and patient outcomes. Asahi Kasei Medical has strategically expanded its market presence through partnerships and collaborations with leading healthcare facilities in Italy. Additionally, the company has made significant strides in mergers and acquisitions, enhancing its product offerings and solidifying its footing within the competitive landscape. By focusing on excellence in manufacturing, rigorous quality assurance, and a customer-centric approach, Asahi Kasei Medical continues to thrive in the rapidly evolving ECMO sector in Italy. ### **Key Companies in the Italy Extracorporeal Membrane Oxygenation Machine Market Include** ## **Italy Extracorporeal Membrane Oxygenation Machine Market Industry Developments** In recent months, the Italy Extracorporeal Membrane Oxygenation Machine Market has seen significant developments, particularly in the context of advancements and innovations by major companies such as LivaNova, Asahi Kasei Medical, Medtronic, and Philips Healthcare. Reportedly, the Italian healthcare landscape has been experiencing increased investments in ECMO technology, driven by a rise in critical care requirements. In March 2023, Fresenius SE and Co. KGaA initiated a collaborative project targeting enhanced ECMO system efficiency, showcasing Italy's focus on cutting-edge medical solutions. Additionally, in January 2023, Medtronic expanded its distribution footprint in Italy, reinforcing its market presence. Meanwhile, Abbott Laboratories launched a series of training programs aimed at healthcare professionals to improve ECMO application and management. There have been no recent notable mergers or acquisitions directly within these companies related to ECMO in Italy, indicating a focus on organic growth strategies. The ongoing demand for ECMO systems reflects the healthcare sector's increasing emphasis on managing severe respiratory and cardiac conditions, leading to a better-equipped infrastructure for critical care units across Italy’s hospitals. ## **Italy Extracorporeal Membrane Oxygenation Machine Market Segmentation Insights** ### **Extracorporeal Membrane Oxygenation Machine Market Application Outlook** ### **Extracorporeal Membrane Oxygenation Machine Market End User Outlook** ### **Extracorporeal Membrane Oxygenation Machine Market Product Type Outlook** ### **Extracorporeal Membrane Oxygenation Machine Market Component Outlook** ## Market Drivers ### Growing Awareness of ECMO Benefits There is a notable increase in awareness regarding the benefits of extracorporeal membrane-oxygenation machines among healthcare professionals and patients in Italy. Educational initiatives and training programs are being implemented to inform medical staff about the advantages of ECMO in critical care settings. This heightened awareness is likely to lead to more frequent utilization of ECMO technology, as healthcare providers recognize its potential to improve survival rates in critically ill patients. Additionally, patient advocacy groups are playing a role in promoting ECMO as a viable treatment option, further driving demand. As understanding of ECMO's capabilities grows, the market is expected to expand, reflecting a shift towards more informed healthcare decisions. ### Investment in Healthcare Infrastructure Italy's ongoing investment in healthcare infrastructure plays a pivotal role in the expansion of the extracorporeal membrane-oxygenation-machine market. The government has allocated substantial funds to modernize hospitals and healthcare facilities, which includes the procurement of advanced medical equipment. This investment is expected to enhance the availability of ECMO machines in critical care units, thereby improving patient access to life-saving treatments. Furthermore, the Italian healthcare system is increasingly focusing on integrating cutting-edge technologies to enhance service delivery. As a result, the market for extracorporeal membrane-oxygenation machines is likely to experience robust growth, driven by the need for state-of-the-art medical solutions in hospitals across the country. ### Rising Incidence of Respiratory Diseases The increasing prevalence of respiratory diseases in Italy is a crucial driver for the extracorporeal membrane-oxygenation-machine market. Conditions such as chronic obstructive pulmonary disease (COPD) and pneumonia are on the rise, necessitating advanced medical interventions. According to health statistics, respiratory diseases account for a significant portion of hospital admissions, leading to a growing demand for extracorporeal membrane oxygenation (ECMO) systems. The ability of ECMO machines to provide life-saving support in critical situations enhances their importance in healthcare settings. As hospitals strive to improve patient outcomes, the adoption of ECMO technology is likely to increase, thereby propelling market growth. This trend indicates a shift towards more sophisticated treatment options, which could reshape the landscape of respiratory care in Italy. ### Technological Innovations in ECMO Systems Technological innovations are transforming the extracorporeal membrane-oxygenation-machine market in Italy. Advances in ECMO technology, such as miniaturization and enhanced biocompatibility, are making these machines more efficient and easier to use. The introduction of portable ECMO systems is particularly noteworthy, as it allows for greater flexibility in patient management, including transport to specialized care facilities. Furthermore, ongoing research and development efforts are likely to yield new features that improve the safety and efficacy of ECMO treatments. As hospitals adopt these innovative solutions, the market for extracorporeal membrane-oxygenation machines is poised for growth, driven by the demand for cutting-edge medical technology. ### Aging Population and Increased Surgical Procedures The demographic shift towards an aging population in Italy is significantly influencing the extracorporeal membrane-oxygenation-machine market. Older individuals are more susceptible to various health complications, often requiring surgical interventions that may necessitate ECMO support. Data indicates that the number of surgical procedures, particularly cardiac surgeries, is on the rise, which correlates with a heightened demand for ECMO systems. As healthcare providers seek to ensure optimal patient outcomes during and after surgery, the reliance on extracorporeal membrane oxygenation technology is expected to grow. This trend underscores the importance of ECMO machines in managing complex surgical cases, thereby driving market expansion in Italy. ## Future Outlook The [Extracorporeal Membrane Oxygenation Machine Market](https://www.marketresearchfuture.com/reports/extracorporeal-membrane-oxygenation-machine-market-8119) is projected to grow at a 5.9% CAGR from 2025 to 2035, driven by technological advancements and increasing healthcare demands. **New opportunities:** - Development of portable ECMO systems for emergency medical services. Expansion of telemedicine integration for remote monitoring solutions. Partnerships with hospitals for ECMO training and certification programs. By 2035, the market is expected to achieve substantial growth, reflecting enhanced healthcare capabilities. ## Segment Insights ### Extracorporeal Membrane Oxygenation Machine Market Application Insights The Italy Extracorporeal Membrane Oxygenation Machine Market, specifically within the Application segment, demonstrates significant relevance to healthcare providers and professionals due to its pivotal role in critical care settings. Various [applications](https://www.marketresearchfuture.com/reports/mhealth-applications-market-3195) such as Cardiac Support, Respiratory Support, and Cardiopulmonary Bypass underline the market's broad utility in managing life-threatening conditions. In the domain of Cardiac Support, the utilization of extracorporeal membrane oxygenation (ECMO) machines facilitates the management of severe cardiac failure, providing crucial time for recovery or surgical intervention and is particularly essential in cases of cardiac arrest or severe heart failure. Respiratory Support caters to an equally important aspect, especially in the treatment of acute respiratory distress syndrome (ARDS) and other severe respiratory conditions, where traditional respiratory support methods may fall short, greatly enhancing patient outcomes through advanced oxygen delivery. Cardiopulmonary Bypass serves as a critical technique during surgical procedures, particularly cardiac surgeries, by temporarily taking over the function of the heart and lungs, allowing surgeons to perform operations with reduced complications, emphasizing its vital importance in the operating room. The dominant presence of these applications within the Italy Extracorporeal Membrane Oxygenation Machine Market reflects a growing need for advanced medical devices that meet rising clinical demand amidst challenges such as chronic diseases and aging populations. As hospitals increasingly adopt cutting-edge technologies, the focus on these applications is likely to deepen, driven by the necessity for better patient care and improved health outcomes. Moreover, innovations in ECMO technology alongside supportive government health initiatives position the Italy Extracorporeal Membrane Oxygenation Machine Market for robust expansion, making it a significant component in the broader healthcare landscape. ### Extracorporeal Membrane Oxygenation Machine Market End User Insights The Italy Extracorporeal Membrane Oxygenation Machine Market is significantly influenced by its End User segment, which comprises Hospitals, Ambulatory Surgical Centers, and Home Care Settings. Hospitals are crucial for the deployment of extracorporeal membrane oxygenation machines due to their advanced infrastructure and comprehensive critical care services, positioning them as the primary users of this technology. Ambulatory Surgical Centers are also important, as they provide convenient and timely access to less complex procedures, thereby facilitating rapid patient recovery with ECMO support when needed. Home Care Settings are gaining traction as they offer a more personalized care approach for patients requiring long-term support, reflecting a growing trend towards at-home medical management, especially in chronic conditions. The demand for these machines in these End User categories continues to rise due to increasing prevalence of respiratory and cardiac diseases, along with advancements in technology and treatment protocols. With a focus on improving patient outcomes and experiences, the market dynamics suggest a balancing act between efficiency and innovative care solutions across these diverse settings in Italy's healthcare landscape. ### Extracorporeal Membrane Oxygenation Machine Market Product Type Insights The Italy Extracorporeal Membrane Oxygenation Machine Market is witnessing a notable segmentation in the Product Type category, which is critical for addressing diverse patient needs and clinical applications. The Venoarterial ECMO system is particularly significant as it provides circulatory support for patients experiencing severe cardiac failure, allowing for temporary stabilization in critical situations. This product type plays a dominant role in emergency and surgical settings, especially in regions where advanced cardiac care is available. Venovenous ECMO focuses on providing respiratory support, primarily utilized for patients with severe respiratory failure or acute respiratory distress syndrome, thus catering to a specific demographic in need of effective oxygenation while preserving the heart's function. Lastly, Arteriovenous ECMO combines both venous and arterial blood flows and is less common but essential in unique clinical scenarios, demonstrating the versatility needed in advanced life support systems. The unique attributes of each ECMO type contribute to the overall growth and demand within the Italy Extracorporeal Membrane Oxygenation Machine Market, as healthcare providers increasingly rely on these technologies to manage critical situations. ### Extracorporeal Membrane Oxygenation Machine Market Component Insights The Component segment of the Italy Extracorporeal Membrane Oxygenation Machine Market plays a crucial role in the overall functionality and efficiency of these life-support systems. Key components such as Membrane Oxygenators are essential for oxygenating blood, thereby significantly improving patient outcomes during critical care situations. Blood Pumps ensure optimal blood circulation and are vital for maintaining stable hemodynamic conditions, contributing to the effectiveness of the extracorporeal membrane oxygenation process. Heat Exchangers are significant in regulating the temperature of blood, preventing complications that may arise due to temperature fluctuations. As Italy faces increasing incidences of respiratory and cardiac conditions, the demand for advanced oxygenation technologies is expected to rise, driving the growth of this segment. The emphasis on quality and technological innovation within these components aligns with the country's commitment to enhancing healthcare delivery. The Component segment shows strong market potential due to continuous improvements in design and functionality, driven by advancements in medical technology and increased investments in healthcare infrastructure. Overall, this segment is poised to make a significant impact on the Italy Extracorporeal Membrane Oxygenation Machine Market as healthcare providers seek more efficient and reliable systems to support critically ill patients. ## Competitive Benchmarking The extracorporeal membrane-oxygenation-machine market in Italy exhibits a dynamic competitive landscape characterized by rapid technological advancements and a growing emphasis on patient-centric solutions. Key players such as Medtronic (US), Getinge (SE), and LivaNova (GB) are at the forefront, leveraging innovation and strategic partnerships to enhance their market positions. Medtronic (US) focuses on integrating advanced digital technologies into its ECMO systems, aiming to improve patient outcomes and streamline clinical workflows. Getinge (SE) emphasizes sustainability in its operations, aligning its product development with eco-friendly practices, which resonates well with the increasing demand for environmentally responsible healthcare solutions. LivaNova (GB) is actively pursuing collaborations with research institutions to foster innovation in ECMO technology, thereby enhancing its competitive edge in the market. The business tactics employed by these companies reflect a concerted effort to optimize supply chains and localize manufacturing processes. The market structure appears moderately fragmented, with several players vying for market share while also collaborating on various fronts. This competitive environment is shaped by the collective influence of these key players, who are not only competing but also forming strategic alliances to enhance their operational capabilities and market reach. In October 2025, Medtronic (US) announced a partnership with a leading Italian hospital to pilot its latest ECMO technology, which integrates AI-driven analytics for real-time patient monitoring. This strategic move is likely to bolster Medtronic's presence in the Italian market, as it demonstrates a commitment to innovation and responsiveness to local healthcare needs. The collaboration is expected to yield valuable insights that could inform future product enhancements and clinical applications. In September 2025, Getinge (SE) launched a new line of ECMO machines designed with a focus on energy efficiency and reduced environmental impact. This initiative aligns with the growing trend towards sustainability in healthcare, potentially positioning Getinge as a leader in eco-conscious medical technology. The introduction of these machines may attract healthcare facilities looking to reduce their carbon footprint while maintaining high standards of patient care. In August 2025, LivaNova (GB) secured a significant contract with the Italian government to supply ECMO machines for public hospitals. This contract not only underscores LivaNova's strong market position but also highlights the increasing reliance on advanced medical technologies in public health systems. The strategic importance of this contract lies in its potential to enhance LivaNova's brand visibility and establish long-term relationships with key stakeholders in the Italian healthcare sector. As of November 2025, the competitive trends in the extracorporeal membrane-oxygenation-machine market are increasingly defined by digitalization, sustainability, and the integration of AI technologies. Strategic alliances are becoming more prevalent, as companies recognize the value of collaboration in driving innovation and improving operational efficiencies. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition towards a focus on technological innovation, supply chain reliability, and the ability to meet the specific needs of healthcare providers. This shift may ultimately redefine the parameters of success in the market. ## Recent News & Developments In recent months, the Italy Extracorporeal Membrane Oxygenation Machine Market has seen significant developments, particularly in the context of advancements and innovations by major companies such as LivaNova, Asahi Kasei Medical, Medtronic, and Philips Healthcare. Reportedly, the Italian healthcare landscape has been experiencing increased investments in ECMO technology, driven by a rise in critical care requirements. In March 2023, Fresenius SE and Co. KGaA initiated a collaborative project targeting enhanced ECMO system efficiency, showcasing Italy's focus on cutting-edge medical solutions. Additionally, in January 2023, Medtronic expanded its distribution footprint in Italy, reinforcing its market presence. Meanwhile, Abbott Laboratories launched a series of training programs aimed at healthcare professionals to improve ECMO application and management. There have been no recent notable mergers or acquisitions directly within these companies related to ECMO in Italy, indicating a focus on organic growth strategies. The ongoing demand for ECMO systems reflects the healthcare sector's increasing emphasis on managing severe respiratory and cardiac conditions, leading to a better-equipped infrastructure for critical care units across Italy’s hospitals. ## Report Scope | MARKET SIZE 2024 | 55.91(USD Million) | | --- | --- | | MARKET SIZE 2025 | 59.21(USD Million) | | MARKET SIZE 2035 | 105.0(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 5.9% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Medtronic (US), Getinge (SE), LivaNova (GB), Fresenius SE (DE), Terumo Corporation (JP), Maquet (DE), Nipro Corporation (JP), Cleveland Medical Devices (US) | | Segments Covered | Application, End User, Product Type, Component | | Key Market Opportunities | Advancements in technology and regulatory support enhance growth potential in the extracorporeal membrane-oxygenation-machine market. | | Key Market Dynamics | Rising demand for extracorporeal membrane-oxygenation machines driven by technological advancements and regulatory support in healthcare. | | Countries Covered | Italy | ## Frequently Asked Questions **Q: What is the current market valuation of the extracorporeal membrane-oxygenation-machine market in Italy?** A: The market valuation was $55.91 Million in 2024. **Q: What is the projected market size for the extracorporeal membrane-oxygenation-machine market by 2035?** A: The projected market size is expected to reach $105.0 Million by 2035. **Q: What is the expected CAGR for the Italy extracorporeal membrane-oxygenation-machine market during the forecast period 2025 - 2035?** A: The expected CAGR is 5.9% during the forecast period 2025 - 2035. **Q: Which application segments are driving the extracorporeal membrane-oxygenation-machine market in Italy?** A: The key application segments include Cardiac Support, Respiratory Support, and Cardiopulmonary Bypass. **Q: What were the market values for the Cardiac Support and Respiratory Support segments in 2024?** A: In 2024, the Cardiac Support segment was valued at $20.0 Million, while the Respiratory Support segment was valued at $25.0 Million. **Q: What is the anticipated growth for the Venovenous ECMO product type by 2035?** A: The Venovenous ECMO product type is projected to grow from $25.0 Million in 2024 to a higher valuation by 2035. **Q: Which companies are considered key players in the Italy extracorporeal membrane-oxygenation-machine market?** A: Key players include Medtronic, Getinge, LivaNova, Fresenius SE, Terumo Corporation, Maquet, Nipro Corporation, and Cleveland Medical Devices. **Q: What are the expected market values for hospitals as an end user segment by 2035?** A: The hospitals segment is expected to grow from $30.0 Million in 2024 to a higher valuation by 2035. **Q: How do the component segments like Membrane Oxygenator and Blood Pumps compare in terms of market value?** A: In 2024, the Membrane Oxygenator was valued at $20.0 Million, while Blood Pumps were valued at $15.0 Million. **Q: What trends are likely to influence the extracorporeal membrane-oxygenation-machine market in Italy in the coming years?** A: Trends may include advancements in technology, increasing demand for ECMO procedures, and a growing focus on patient care. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/italy-extracorporeal-membrane-oxygenation-machine-market-50832*